Commercial studies and non-commercial studies on the portfolio of the National Institute of Health Research (NIHR)
The Royal Free London NHS Foundation Trust takes part in a harmonised process of single research governance approval for commercial studies and non-commercial studies on the portfolio of the National Institute of Health Research (NIHR).
As part of the harmonised process, research studies are reviewed by one of four permission centres:
- University College London Hospitals (UCLH)
- North Central London Research Consortium (NOCLOR)
- Barts Health NHS Trust
- Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH)
Your study will be allocated to one of the permission centres based on its clinical theme. The review will include, where appropriate, the costing and contracts review, pharmacy and medical exposure review. The permission centre will provide study-wide approval for all member organisations taking part in the harmonised process. This reduces the need for duplication of checks for each hospital and allows sponsors to open more sites at the same time.
All other studies
The Royal Free research and development team will facilitate review of all other research applications, including the costing and contracts review, pharmacy and medical exposure review.
Please make your research submission to firstname.lastname@example.org. A member of the team of the team will be allocated to discuss your project with you and carry out the review.
If you would like to find out more about the research approval process, please see:
- SOP003 Reporting amendments
- SOP005 GCP training for research staff
- SOP014 Contract negotiation and review
- SOP018-1 NHS permission for commercial harmonisation studies
- SOP018-2 NHS permission for non-commercial harmonisation studies
- SOP018-3 NHS permission for non-commercial non-harmonisation studies